Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liposomal Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03043547
What this trial is testing

Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies

Who this might be right for
Cholangiocarcinoma Non-resectableCholangiocarcinoma MetastaticCholangiocarcinoma of the Gallbladder+1 more
AIO-Studien-gGmbH 100
Testing effectiveness (Phase 2)Study completedNCT04752696
What this trial is testing

Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Cardiff Oncology 41
Early research (Phase 1)Study completedNCT00734682
What this trial is testing

A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+1 more
University of California, San Francisco 34
Testing effectiveness (Phase 2)Ended earlyNCT03736720
What this trial is testing

Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Who this might be right for
Locally Advanced Digestive System Neuroendocrine CarcinomaLocally Advanced Pancreatic Neuroendocrine CarcinomaMetastatic Digestive System Neuroendocrine Carcinoma+5 more
Roswell Park Cancer Institute 11
Early research (Phase 1)Study completedNCT05086822
What this trial is testing

Irinotecan Hydrochloride Liposome in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07004712
What this trial is testing

Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 46
Not applicableUnknownNCT05587387
What this trial is testing

Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea

Who this might be right for
Pancreatic Neoplasms
Yonsei University 250
Testing effectiveness (Phase 2)Looking for participantsNCT06801730
What this trial is testing

Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma

Who this might be right for
Glioma
Zhifeng Tian,MD 38
Testing effectiveness (Phase 2)UnknownNCT06437678
What this trial is testing

Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer

Who this might be right for
Gastric Cancer
Zhejiang Cancer Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06816914
What this trial is testing

Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial

Who this might be right for
Resectable Pancreatic Adenocarcinoma
Taichung Veterans General Hospital 84
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06513455
What this trial is testing

Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Harbin Medical University 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648525
What this trial is testing

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Harbin Medical University 68
Early research (Phase 1)Looking for participantsNCT06766266
What this trial is testing

Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment

Who this might be right for
Non-Muscle Invasive Bladder Urothelial Carcinoma
First Affiliated Hospital of Chongqing Medical University 18
Post-approval studies (Phase 4)Not Yet RecruitingNCT06485739
What this trial is testing

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine Tumors
First Affiliated Hospital Xi'an Jiaotong University 20
Testing effectiveness (Phase 2)UnknownNCT05363007
What this trial is testing

Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Cancer
National Taiwan University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03693677
What this trial is testing

First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI

Who this might be right for
Metastatic Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 288
Testing effectiveness (Phase 2)Study completedNCT04727853
What this trial is testing

Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)
CSPC Ouyi Pharmaceutical Co., Ltd. 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03764553
What this trial is testing

Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer

Who this might be right for
Esophageal Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 320
Not applicableUnknownNCT06155136
What this trial is testing

RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan

Who this might be right for
Pancreatic Cancer Metastatic
Servier Affaires Médicales 163
Testing effectiveness (Phase 2)Looking for participantsNCT07044921
What this trial is testing

Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.

Who this might be right for
Colorectal Cancer Metastatic
Chinese PLA General Hospital 30
Next Page